Critical pre-examination variables in the hemostasis laboratory and their quality indicators

被引:31
作者
Adcock, Dorothy M. [1 ]
Favaloro, Emmanuel J. [2 ]
Lippi, Giuseppe [3 ]
机构
[1] Lab Corp Amer Holdings, Colorado Coagulat, Englewood, CO USA
[2] Westmead Hosp, Sydney Ctr Thrombosis & Haemostasis, Dept Haematol, ICPMR,Pathol West, Westmead, NSW, Australia
[3] Univ Verona, Clin Biochem Sect, Verona, Italy
关键词
Pre-examination variables; Quality indicators; Laboratory errors; Coagulation testing; Preanalytical variables; PREANALYTICAL VARIABLES; FACTOR INHIBITORS; COAGULATION; TIME; PLASMA; BLOOD; SAMPLES; COLLECTION; STORAGE; ERRORS;
D O I
10.1016/j.clinbiochem.2016.08.022
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The total testing process comprises a number of phases of laboratory testing, which can be broadly considered as comprising pre-examination, examination and post-examination activities. Although each phase is crucial to providing accurate and meaningful laboratory results, the pre-examination phase of testing is where most laboratory errors currently occur, and thus requires special attention. The activities in this phase include sample collection, handling, transportation, processing and storage, which are frequently outside the control of the laboratory performing the tests. Samples for hemostasis testing are particularly vulnerable to pre-analytical variables, which may ultimately lead to inappropriate test results. We outline here several strategies to mitigate potential problems in the pre-examination phase. We also recommend the implementation of several processes to reduce errors. (C) 2016 Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.
引用
收藏
页码:1315 / 1320
页数:6
相关论文
共 54 条
[1]   The effect of time and temperature variables on routine coagulation tests [J].
Adcock, D ;
Kressin, D ;
Marlar, RA .
BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (06) :463-470
[2]   Minimum specimen volume requirements for routine coagulation testing - Dependence on citrate concentration [J].
Adcock, DM ;
Kressin, DC ;
Marlar, RA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1998, 109 (05) :595-599
[3]  
Adcock DM, 1997, AM J CLIN PATHOL, V107, P105
[4]  
[Anonymous], SO YOURE GOING COLLE
[5]  
[Anonymous], GP21A3 CLSI
[6]  
[Anonymous], G21A5 CLSI
[7]  
[Anonymous], 2010, J BIOMED LAB SCI
[8]  
[Anonymous], GP26A4 CLSI
[9]  
Awad Mohammed A, 2004, Hematology, V9, P333, DOI 10.1080/10245330400010646
[10]   Stability of low molecular weight heparin anti-factor Xa activity in citrated whole blood and plasma [J].
Birri, Nicole ;
Baumgartner, Daniela ;
Conte, Tiziana ;
Huynh, Anh ;
Weller, Katja ;
Pavicic, Marko ;
Reusser, Marianne ;
Siegenthaler, Ilse ;
Barizzi, Gabriela ;
Alberio, Lorenzo .
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (05) :629-631